Congratulations to @lama_ghazi @ajpeixoto @fperrywilson et al on their @AJKDonline paper out this week exploring whether there is heterogeneity in IV antihypertensives' effect on AKI incidence among patients who develop severe HTN during hospitalization!👇 https://t.co/FJbel3VKoL

#Hypertension24 officially begins tomorrow (Opening Ceremony). Come see breaking #Hypertension #research and network with us in Chicago, September 5th-8th. There’s still time to register https://t.co/XlRPv7GtIF…. I hope to see you there! @AHAScience @AHAMeetings

#Commentary on paper from authors @MuntnerPaul @lama_ghazi and colleagues: The Rising Prevalence of Multiple Chronic Conditions Among US Adults With Hypertension https://t.co/enTYsbfdCK 🔒

Really nice paper by @MuntnerPaul @lama_ghazi @fotikat on the impact of PREVENT for treatment among adults with stage 1 hypertension. Predicted Cardiovascular Risk by the PREVENT Equations in US Adults With Stage 1 Hypertension | Hypertension

Come join TAC for #CHAMP2024. ⁦@MM_Santisteban⁩ and the CHAMP organizing team have an exciting luncheon planned! ⁦@CouncilonHTN⁩ ⁦@AHAMeetings⁩

Spots are filling up fast for #CHAMP24 at @AHAScience #Hypertension24. @MM_Santisteban and the CHAMP organizing committee have an exciting event planned! @CouncilonHTN https://t.co/z6AwUnoRtX

If you havent registered yet for the 🌟 #CHAMP24 event at this year’s @AHAScience #Hypertension24 @CouncilonHTN coordinated by @CamGMcCarthy @MM_Santisteban & #CHAMP organizing committee dont delay! Definitely fun as well as great insight provided into the journey we are all

🔥 Review: "#Biomarkers vs #Machines: The Race to Predict Acute #Kidney Injury" by @lama_ghazi, @ThomasDurantMD, @ClinChemJoe & others @Yale @YaleLabMed #MedTwitter #LabMedX #PathTwitter #nephrology #emergencymed 👇

1/ 🆕Scientific Statement from the American Heart Association: The Management of Elevated Blood Pressure in the Acute Care Setting 📷 Care pathways for the management of BP in the acute care setting and transitions of care.

1/ Elevated BP is common in the acute care setting & can appear as asymptomatic or w/ new or worsening symptoms. This aims to synthesize available evidence, provide best practice suggestions, identify gaps in managing elevated inpatient BP & identify areas for further research.

Excited to see the AHA Statement on elevated BP in the inpatient setting published. It was great working with this amazing group @adambress @taraichang @TimAndersonMD and all!

Should we rethink our approach to treating inpatient asymptomatic hypertension? The terms "hypertensive urgency" and "hypertensive crisis" might be outdated, potentially leading to inappropriate treatment. This new AHA Scientific Statement suggests it's time for a change.

Orthostatic Hypotension in Adults With Hypertension: A Scientific Statement From the American Heart Association is out @AHAScience @HyperAHA Excited to have been part of the writing team!

Fresh off the press! Our scientific statement on orthostatic hypotension in adults with hypertension! The writing team put a lot of heart into this really informative work!

Thank @DrWanpen & @GiaconaJohn for an insightful commentary.

Excited to see our paper published! My first senior author manuscript. This wouldn’t have been possible without @fperrywilson and @ajpeixoto guidance

So happy to see this out! Huge thanks to the leadership of brilliant @lama_ghazi and @jordy_bc, who stuck with me on this project for >2 years!! @MRrenaldoc @PDrawz @matthewweir Orthostatic hypotension, orthostatic HTN, and Ambulatory Blood Pressure https://t.co/rzcxRzOf0b

Master the art of data analysis and interpretation with a six-part video curriculum: “Basics of Statistics for a Successful Start in Clinical Research” ➡️ https://t.co/3PBdv3eZ3C #ISNyoung #ThisIsISN – Advancing kidney health worldwide. Together.

Our latest paper in @ESC_Journals @ehj_ed #EHJ: The results of the PROMPT-AHF trial! @yaleHFdoc @fperrywilson @nihardesai927 @lama_ghazi @oconnkyle @ralphadelta @YaleCardiology @YaleIMed https://t.co/FrorRlQq3G